Agios Pharmaceuticals Inc. Stock Performance
as on June 19, 2026 at 2:16 pm IST
Day's Low
Day's High
$33.50$34.33
1.93%
Downside
0.50%
Upside
52 Week's Low
52 Week's High
$22.24$46.0034.89%
Downside
34.66%
Upside
Agios Pharmaceuticals Inc. share price movements today
- Previous Close
- $33.08
- Open
- $33.83
- Volume
- 988.8K
- Day's Low - High
- $33.50 - $34.33
- 52 Week Low - High
- $22.24 - $46.00
Agios Pharmaceuticals Inc. Historical Returns
- 1 Month Return
- + 21.39 %
- 3 Month Return
- + 22.61 %
- 1 Year Return
- -0.73 %
- 3 Year Return
- + 26.85 %
- 5 Year Return
- -39.9 %
Agios Pharmaceuticals Inc. Stock Fundamentals & Key Indicators
Check Agios Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.0B
EPS (TTM)
-6.1788
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-470.3M
Revenue (TTM)
66.0M
Profit Margin
0.00%
Return On Equity TTM
-32.81%
Agios Pharmaceuticals Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Agios Pharmaceuticals Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $2.0B | -39.9% | NA | 0.00% | NA | |
| BUY | $37.1B | 60.79% | 69.87 | 12.55% | NA | |
| BUY | $114.6B | 139.12% | 26.8 | 35.51% | NA | |
| BUY | $63.9B | 14.22% | 14.88 | 29.65% | 0.59% |
Stock Returns calculator for Agios Pharmaceuticals Inc. Stock including INR - Dollar returns
The Agios Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Agios Pharmaceuticals Inc. investment value today
Current value as on today
₹1,08,137
Returns
₹8,137
(+8.14%)
Returns from Agios Pharmaceuticals Inc. Stock
Dollar Impact
₹8,863 (+8.86%)
Analyst Recommendation on Agios Pharmaceuticals Inc. Stock
Based on 15 analysts
73.33%
Buy
26.67%
Hold
0.00%
Sell
Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for Agios Pharmaceuticals Inc.. Average target price of $40.75
Agios Pharmaceuticals Inc. Share Price Target
Get share price movements and forecasts by analysts on Agios Pharmaceuticals Inc..
What analysts predicted
16.17%UPSIDE
Target Price
$40.75
Current Price
$34.16
Analyzed by
15 Analysts
Target
$40.75
Agios Pharmaceuticals Inc. target price $40.75, a slight upside of 16.17% compared to current price of $34.16. According to 15 analysts rating.
Indian Investors' Interest in Agios Pharmaceuticals Inc. Stock
Search interest for Agios Pharmaceuticals Inc. Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Agios Pharmaceuticals Inc. Quarterly Profit & Loss
All numbers in Millions USD
Agios Pharmaceuticals Inc. Annual Profit & Loss
All numbers in Millions USD
Agios Pharmaceuticals Inc. Quarterly Cash Flow
All numbers in Millions USD
Agios Pharmaceuticals Inc. Annual Cash Flow
All numbers in Millions USD
Agios Pharmaceuticals Inc. News & Key Events
Today's Timeline - 24 December
Wed, 10:37 AM
-Agios Pharmaceuticals announces FDA approval for AQVESME (mitapivat) for anemia in thalassemia, shares fell 1.4% to $24.59.
Wed, 06:01 PM
-Agios shares rise 9.80% to $27.00 premarket after FDA approval of AQVESME for thalassemia-related anemia.
Wed, 06:48 PM
-FDA expands approval for mitapivat, expected to generate $320 million additional peak revenue opportunity.
Today's Timeline - 24 December
Wed, 10:33 PM
-Management outlines marketing plans for AQVESME, targeting 4,000 patients with a price of $425,000 annually.
Insights on Agios Pharmaceuticals Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, AGIO stock has moved up by 7.4%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 8.72M → 20.74M (in $), with an average increase of 18.1% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, AGIO has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -108.03M → -99.11M (in $), with an average increase of 9.0% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 20.4%
About Agios Pharmaceuticals Inc.
| Organisation | Agios Pharmaceuticals Inc. |
| Headquarters | 88 Sidney Street, Cambridge, MA, United States, 02139 |
| Industry | Biotechnology |
| CEO | Mr. Brian M. Goff M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Agios Pharmaceuticals Inc.
Name | Title |
|---|---|
Dr. Craig B. Thompson M.D. | Co-Founder |
Mr. James William Burns | Chief Legal Officer |
Dr. Sarah Gheuens M.D., Ph.D. | Chief Medical Officer and Head of Research & Development |
Dr. Krishnan Viswanadhan M.B.A., Pharm.D. | Chief Strategy & Operations Officer |
Dr. Lewis clayton Cantley Ph.D. | Co-Founder |
Dr. Tak Wah Mak D.Sc., FRSC, Ph.D. | Co-Founder |
Dr. Shin-San Su Ph.D. | Co-Founder |
Mr. T. J. Washburn | VP, Controller & Principal Accounting Officer |
Mr. Brian M. Goff M.B.A. | CEO & Director |
Ms. Cecilia Jones | Chief Financial Officer |
FAQs
What is Agios Pharmaceuticals Inc. share price today?
Agios Pharmaceuticals Inc. share price today is $34.16 as on at the close of the market. Agios Pharmaceuticals Inc. share today touched a day high of $34.33 and a low of $33.5.
What is the 52 week high and 52 week low for Agios Pharmaceuticals Inc. share?
Agios Pharmaceuticals Inc. share touched a 52 week high of $46 on and a 52 week low of $22.24 on . Agios Pharmaceuticals Inc. stock price today i.e. is closed at $34.16,which is 25.74% down from its 52 week high and 53.60% up from its 52 week low.
What is Agios Pharmaceuticals Inc.'s market capitalisation today?
Agios Pharmaceuticals Inc. market capitalisation is $0.00T as on .
How to invest in Agios Pharmaceuticals Inc. Stock (AGIO) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Agios Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Agios Pharmaceuticals Inc. Shares that will get you 0.0439 shares as per Agios Pharmaceuticals Inc. share price of $34.16 per share as on June 19, 2026 at 8:46 am IST.
What is the minimum amount required to buy Agios Pharmaceuticals Inc. Stock (AGIO) from India?
Indian investors can start investing in Agios Pharmaceuticals Inc. (AGIO) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Agios Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Agios Pharmaceuticals Inc. share’s latest price of $34.16 as on June 19, 2026 at 8:46 am IST, you will get 0.2927 shares of Agios Pharmaceuticals Inc.. Learn more about
fractional shares .
What are the returns that Agios Pharmaceuticals Inc. has given to Indian investors in the last 5 years?
Agios Pharmaceuticals Inc. stock has given -39.9% share price returns and 27.24% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?